首页 | 本学科首页   官方微博 | 高级检索  
     

长春瑞滨联合顺铂治疗晚期非小细胞肺癌38例疗效观察
引用本文:赵宏亮. 长春瑞滨联合顺铂治疗晚期非小细胞肺癌38例疗效观察[J]. 肿瘤基础与临床, 2005, 18(6): 409-410
作者姓名:赵宏亮
作者单位:许昌市中心医院肿瘤科,河南,许昌,461000
摘    要:目的观察NP方案治疗晚期非小细胞肺癌的疗效与毒性。方法应用长春瑞滨25 mg/m2静脉点滴,第1,8天,DDP 80~100mg/m2静脉点滴,第1,2天。结果38例无CR,PR 16例,NC 16例,PD 6例,总有效率42.1%。结论长春瑞滨联合顺铂治疗晚期NSCLC有效率高,毒副反应能耐受。

关 键 词:长春瑞滨  顺铂  非小细胞肺癌  化疗
文章编号:1003-1464(2005)06-0409-02
修稿时间:2005-03-08

Therapy Observation of Vinorelbine Combined with Cisplation in the Treatment of Advanced Non-Small Cell Lung Cancer
Zhao Hongliang. Therapy Observation of Vinorelbine Combined with Cisplation in the Treatment of Advanced Non-Small Cell Lung Cancer[J]. Journal of Basic and Clinical Oncology, 2005, 18(6): 409-410
Authors:Zhao Hongliang
Abstract:Objective To investigate the effect and toxicity of treatment of non-small cell lung cancer with NVB and DDP.Methods NVB(25 mg/m~2) in the 1st day and 8th day,and DDP 80-100 mg/m~2 in two days were given.Results There were 0 CR,16 PR,16 NC and 6 PD in the 38 patients.The response rate was 42.1%.Conclusion Treatment of non-small cell lung cancer with NVB and DDP was efficient and the toxicity was able to be tolerable.
Keywords:NVB  DDP  non-small cell lung cancer  chemotherapy
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号